Endovia Health Sciences, Inc. — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Endovia Health Sciences filed an 8-K on 2026-10-15 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits). The filing contains no substantive disclosure of the agreement's terms, counterparty, dollar amounts, share counts, or business impact—only XBRL data files and metadata. The actual agreement details are not provided in the available filing text.
Why this rating
Material agreement trigger is inherently significant for $6.5M-cap company, but complete lack of disclosure prevents assessment of actual business impact or valuation risk.
Extracted items
- 1.01 material agreement
- 9.01 exhibits
Price action (we called it neutral)
before filing · preread $0.15 ▼ 0.88% | at our read · unknown $0.15 | +10 min · unknown $0.15 ▲ 0.00% | +30 min · unknown $0.14 ▼ 1.36% | +1 hr · unknown $0.14 ▼ 1.36% | +4 hrs · unknown $0.14 ▼ 3.40% |
The stock had already moved +0.89% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.